{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T09:42:32Z","timestamp":1756460552634},"reference-count":12,"publisher":"Japanese Society of Internal Medicine","issue":"19","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2019,10,1]]},"DOI":"10.2169\/internalmedicine.2537-18","type":"journal-article","created":{"date-parts":[[2019,6,26]],"date-time":"2019-06-26T22:03:18Z","timestamp":1561586598000},"page":"2871-2874","source":"Crossref","is-referenced-by-count":17,"title":["Elevated Adenosine Deaminase Levels in the Cerebrospinal Fluid in Immune Checkpoint Inhibitor-induced Autoimmune Encephalitis"],"prefix":"10.2169","volume":"58","author":[{"given":"Satoru","family":"Fujiwara","sequence":"first","affiliation":[{"name":"Department of Neurology, Kobe City Medical Center General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoya","family":"Mimura","sequence":"additional","affiliation":[{"name":"Department of Neurology, Kobe City Medical Center General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hajime","family":"Yoshimura","sequence":"additional","affiliation":[{"name":"Department of Neurology, Kobe City Medical Center General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daichi","family":"Fujimoto","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Kobe City Medical Center General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Munehiro","family":"Ito","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Kobe City Medical Center General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryobu","family":"Mori","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Kobe City Medical Center General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiro","family":"Ito","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Kobe City Medical Center General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keisuke","family":"Tomii","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Kobe City Medical Center General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michi","family":"Kawamoto","sequence":"additional","affiliation":[{"name":"Department of Neurology, Kobe City Medical Center General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuo","family":"Kohara","sequence":"additional","affiliation":[{"name":"Department of Neurology, Kobe City Medical Center General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","unstructured":"1. Abdel-Wahab N, Shah M, Suarez-Almazor ME. Adverse events associated with immune checkpoint blockade in patients with cancer: a systematic review of case reports. PLoS One 11: e0160221, 2016."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Blackmon JT, Viator TM, Conry RM. Central nervous system toxicities of anti-cancer immune checkpoint blockade. J Neurol Neuromed 1: 39-45, 2016.","DOI":"10.29245\/2572.942X\/2016\/4.1040"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Ito M, Fujiwara S, Fujimoto D, et al. Rituximab for nivolumab plus ipilimumab induced encephalitis in a small-cell lung cancer patient. Ann Oncol 28: 2318-2319, 2017.","DOI":"10.1093\/annonc\/mdx252"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Tuon FF, Higashino HR, Lopes MIBF, et al. Adenosine deaminase and tuberculous meningitis. A systematic review with meta-analysis. Scand J Infect Dis 42: 198-207, 2010.","DOI":"10.3109\/00365540903428158"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Nakae Y, Kuroiwa Y. A case of listeria meningitis showed high levels of adenosine deaminase in cerebrospinal fluid. Rinsho Shinkeigaku (Clin Neurol) 49: 590-593, 2014 (in Japanese, Abstract in English).","DOI":"10.5692\/clinicalneurol.49.590"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Dominguez Artiga MJ, Holanda Pe\u00f1a MS, Velasco Montes J, Orozco Abril RM, Teja Barbero JL. Bacterial meningitis with extraordinarily high ADA due to <i>Streptococcus pneumoniae<\/i>. Med Intensiva 34: 288-289, 2010.","DOI":"10.1016\/j.medin.2009.03.003"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Tanaka Y, Satomi K. Cryptococcal meningitis associated with increased adenosine deaminase in the cerebrospinal fluid. Springerplus 5: 2093, 2016.","DOI":"10.1186\/s40064-016-3767-z"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Nishihara H, Omoto M, Ogasawara J, Koga M, Kawai M, Kanda T. Leptomeningeal gliomatosis with high levels of adenosine deaminase in the cerebrospinal fluid. Rinsho Shinkeigaku (Clin Neurol) 54: 308-312, 2014 (in Japanese, Abstract in English).","DOI":"10.5692\/clinicalneurol.54.308"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Taguchi S, Niwa J, Tokui K, et al. Potent primary leptomeningeal lymphoma masquerading as tuberculous meningitis - a case report. Rinsho Shinkeigaku (Clin Neurol) 52: 416-420, 2012 (in Japanese, Abstract in English).","DOI":"10.5692\/clinicalneurol.52.416"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Kimura T, Fukushima S, Miyashita A, et al. Myasthenic crisis and polymyositis induced by one dose of nivolumab. Cancer Sci 107: 1055-1058, 2016.","DOI":"10.1111\/cas.12961"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Williams Tenya J, Benavides David R, Patrice Kelly-Ann, et al. Association of autoimmune encephalitis with combined immune checkpoint inhibitor treatment for metastatic cancer. JAMA Neurol 73: 928-933, 2016.","DOI":"10.1001\/jamaneurol.2016.1399"},{"key":"12","unstructured":"12. Brahmer Julie R, Lacchetti Christina, Schneider Bryan J, et al.; National Comprehensive Cancer Network. Management of immune-related adverse events in patients treated with immune checkpoint inhibitor therapy: American Society of Clinical Oncology Clinical Practice Guideline. J Clin Oncol 36: 1714-1768, 2018."}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/58\/19\/58_2537-18\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,5]],"date-time":"2019-10-05T03:42:09Z","timestamp":1570246929000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/58\/19\/58_2537-18\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,1]]},"references-count":12,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.2537-18","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,1]]}}}